Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
4-disease-suspicion [2018/07/31 17:55] thorsten [4.5 Actions upon confirmation of the disease] |
4-disease-suspicion [2018/08/01 16:05] (current) thorsten |
||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | Surveillance designers should define and/or document how a suspected case of the hazard of interest is defined and reported to the relevant authorities. This is relevant to __**passive surveillance**__ components where the collection of surveillance data is observer -initiated.\\ \\ For __**active surveillance components**__ a designer may skip ahead to [[/6-%20Testing%20protocol|section 6]].\\ \\ | + | Surveillance designers should define and/or document how a suspected case of the hazard of interest is defined and reported to the relevant authorities. This is relevant to __**passive surveillance**__ components where the collection of surveillance data is observer -initiated.\\ \\ For __**active surveillance components**__ a designer may skip ahead to [[/6-Testing-protocol|section 6]].\\ \\ |
| ===== 4.1 Criteria for identification of suspicions ===== | ===== 4.1 Criteria for identification of suspicions ===== | ||
| For the hazard of interest, the surveillance designer should outline the definition or criteria used to identify a suspect case (for instance which clinical signs). It may be useful to consider: Likelihood of recovery; description of possible clinical states (Subclinical, Subacute, Acute, Chronic, Mortality) and Differential diagnosis.\\ \\ | For the hazard of interest, the surveillance designer should outline the definition or criteria used to identify a suspect case (for instance which clinical signs). It may be useful to consider: Likelihood of recovery; description of possible clinical states (Subclinical, Subacute, Acute, Chronic, Mortality) and Differential diagnosis.\\ \\ | ||
| Line 16: | Line 16: | ||
| \\ | \\ | ||
| - | | [[/3-Target-population|{{/file/view/previous.png/549397298/176x61/previous.png|previous.png}}]]\\ | [[/5-Enhancements|{{/file/view/next.png/549397294/190x62/next.png|next.png}}]]\\ | | + | | [[/3-Target-population|{{ :files:previous.png?nolink&200 |}}]]\\ | [[/5-Enhancements|{{ :files:next.png?nolink&200 |}}]]\\ | |